ZA200707440B - Compositions and methods of making sustained release liquid formulations - Google Patents

Compositions and methods of making sustained release liquid formulations

Info

Publication number
ZA200707440B
ZA200707440B ZA200707440A ZA200707440A ZA200707440B ZA 200707440 B ZA200707440 B ZA 200707440B ZA 200707440 A ZA200707440 A ZA 200707440A ZA 200707440 A ZA200707440 A ZA 200707440A ZA 200707440 B ZA200707440 B ZA 200707440B
Authority
ZA
South Africa
Prior art keywords
compositions
methods
sustained release
liquid formulations
release liquid
Prior art date
Application number
ZA200707440A
Other languages
English (en)
Inventor
Tengler Mark
Lockhart Daniel
Taskey Paul
Mcmahen Russell Lee
Original Assignee
Neos Therapeutics Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neos Therapeutics Lp filed Critical Neos Therapeutics Lp
Publication of ZA200707440B publication Critical patent/ZA200707440B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA200707440A 2005-02-28 2007-08-30 Compositions and methods of making sustained release liquid formulations ZA200707440B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/068,124 US8318210B2 (en) 2005-02-28 2005-02-28 Compositions and methods of making sustained release liquid formulations

Publications (1)

Publication Number Publication Date
ZA200707440B true ZA200707440B (en) 2009-10-28

Family

ID=36932179

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707440A ZA200707440B (en) 2005-02-28 2007-08-30 Compositions and methods of making sustained release liquid formulations

Country Status (8)

Country Link
US (3) US8318210B2 (xx)
EP (1) EP1855613A4 (xx)
CN (1) CN101170963B (xx)
AU (1) AU2006218830B2 (xx)
CA (1) CA2599585C (xx)
MX (1) MX2007010541A (xx)
WO (1) WO2006093838A2 (xx)
ZA (1) ZA200707440B (xx)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US20070088332A1 (en) * 2005-08-22 2007-04-19 Transcutaneous Technologies Inc. Iontophoresis device
US20070092553A1 (en) * 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
SI3095447T1 (sl) 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
CN102488652B (zh) 2006-03-16 2014-06-18 特瑞斯制药股份有限公司 含有药物-离子交换树脂复合物的经修饰释放的制剂
PT2679228T (pt) * 2006-06-21 2018-04-16 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
EP2123259A1 (en) * 2007-01-16 2009-11-25 Hokkaido University Liposome preparation for iontophoresis having antioxidant component encapsulated therein
WO2008103345A2 (en) 2007-02-19 2008-08-28 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
PL2148684T3 (pl) * 2007-04-25 2013-06-28 Cytochroma Inc Sposób leczenia niedoboru i deficytu witaminy D
EP2148685A4 (en) * 2007-04-25 2010-07-28 Cytochroma Inc METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
PT2148661E (pt) 2007-04-25 2013-03-06 Proventiv Therapeutics Llc Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
EP3335712A1 (en) 2007-04-25 2018-06-20 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
WO2009032913A2 (en) * 2007-09-04 2009-03-12 The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services Thermal inactivation of rotavirus
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
CN106853250A (zh) 2008-04-02 2017-06-16 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
DE102008021473A1 (de) * 2008-04-29 2009-11-12 Heraeus Kulzer Gmbh Mit Antiplaque-Wirkstoff(en) ausgestattete Dentalmaterialien
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US8859003B2 (en) 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
TWI479018B (zh) * 2009-07-24 2015-04-01 Buck Chemie Gmbh 施用在衛浴用品上的附著劑
US8470375B1 (en) 2010-01-05 2013-06-25 Neos Therapeutics, Lp Method of formulating and designing liquid drug suspensions containing ion exchange resin particles
WO2011107855A2 (en) 2010-03-04 2011-09-09 Torrent Pharmaceuticals Limited Sustained release oral liquid suspension dosage form
PT2552484T (pt) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Métodos e composições para redução dos níveis de parafróides
US9050289B2 (en) 2010-06-11 2015-06-09 Gm Pharmaceuticals, Inc. Pharmaceutical compositions
EP2726066B1 (en) 2011-06-28 2021-03-31 Neos Therapeutics, LP Dosage forms of amphetamine for oral administration
US10137280B2 (en) 2011-06-30 2018-11-27 Incube Labs, Llc System and method for treatment of hemorrhagic stroke
US10130514B2 (en) 2011-09-26 2018-11-20 Incube Labs, Llc System and method for delivery of a therapeutic agent to the inner ear
WO2013090439A1 (en) * 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations of guaifenesin
US20150005269A1 (en) * 2012-01-03 2015-01-01 Rhode Island Hospital Treatment of Heart Failure and Sudden Cardiac Death
WO2014028610A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
EP2916818B1 (en) * 2012-11-09 2017-02-01 Scidose LLC Enema composition for treatment of ulcerative colitis having long term stability
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
ITTO20121155A1 (it) * 2012-12-27 2014-06-28 Fond Istituto Italiano Di Tecnologia Microparticella multistrato comprendente fluorofori
KR20160148723A (ko) * 2013-02-28 2016-12-26 화이자 인코포레이티드 증가된 안정성의 신규한 액체 조성물
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
PL3137060T5 (pl) 2014-05-01 2024-04-08 Sun Pharmaceutical Industries Ltd Kompozycje zawiesinowe o przedłużonym uwalnianiu
MX2017001332A (es) 2014-07-30 2017-08-02 Sun Pharmaceutical Ind Ltd Envase con camara.doble.
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
EP3193925A2 (en) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
CN107205630A (zh) * 2014-12-04 2017-09-26 M·特罗尔萨斯 用于图像撷取控制的胶囊涂层
EP3288549A4 (en) * 2015-05-01 2020-01-15 Sun Pharmaceutical Industries Limited ORAL LIQUID COMPOSITIONS OF GUANFACIN
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
TWI681004B (zh) 2015-12-30 2020-01-01 美商聖高拜陶器塑膠公司 改質氮化物顆粒、寡聚物官能化氮化物顆粒、基於聚合物之複合材料及其形成方法
MX2018011820A (es) 2016-03-28 2019-01-24 Opko Ireland Global Holdings Ltd Metodos de tratamiento con vitamina d.
EP3445350A4 (en) * 2016-04-20 2019-12-25 Sun Pharmaceutical Industries Limited LIQUID COMPOSITIONS FROM GUANFACIN WITH EXTENDED RELEASE
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
WO2019070818A2 (en) * 2017-10-04 2019-04-11 Panacea Biomatx, Inc. SUSPENSION OF ENCAPSULATED PHARMACEUTICAL PRODUCTS AND METHODS OF MAKING AND USING SAME
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2019126218A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
WO2019126215A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
WO2019126214A1 (en) 2017-12-18 2019-06-27 Tris Pharma, Inc. Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
CN108640806B (zh) * 2018-08-27 2020-05-22 安徽理工大学 一种地下矿用胶状乳化炸药及其制备方法
CN113993523A (zh) 2019-04-17 2022-01-28 指南针探路者有限公司 用赛洛西宾治疗抑郁症和其他各种病症
CN113512281B (zh) * 2021-08-11 2022-12-30 海南赛诺实业有限公司 一种改性pga材料及其制备方法，以及改性pga薄膜
CN117398347B (zh) * 2023-12-15 2024-03-19 山东国邦药业有限公司 一种替米考星干混悬剂及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4438150A (en) * 1982-09-09 1984-03-20 The Quaker Oats Company Process for preparing an instant baby cereal porridge product
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
US5672358A (en) * 1994-06-21 1997-09-30 Ascent Pharmaceuticals, Inc. Controlled release aqueous emulsion
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
SE505146C2 (sv) 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
US5980945A (en) 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
US6039470A (en) * 1997-03-24 2000-03-21 Conwell; Allyn B. Particulate mixing system
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
WO1999006023A1 (en) 1997-07-29 1999-02-11 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
FR2781373B1 (fr) 1998-07-07 2001-09-21 Pf Medicament Formulations thixotropes pour le remplissage de gelules
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
EP1292381B1 (en) 2000-05-03 2009-07-15 D'SILVA, Joe Process and device for producing liquid dosage formulations
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US6787179B2 (en) * 2001-06-29 2004-09-07 Ethicon, Inc. Sterilization of bioactive coatings
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition

Also Published As

Publication number Publication date
US20140093577A1 (en) 2014-04-03
US8318210B2 (en) 2012-11-27
EP1855613A4 (en) 2013-01-02
CN101170963A (zh) 2008-04-30
MX2007010541A (es) 2008-01-28
CA2599585C (en) 2014-05-20
WO2006093838A2 (en) 2006-09-08
CN101170963B (zh) 2011-04-20
US20130084340A1 (en) 2013-04-04
AU2006218830B2 (en) 2012-08-30
US20060193877A1 (en) 2006-08-31
WO2006093838A3 (en) 2007-03-29
EP1855613A2 (en) 2007-11-21
US9522120B2 (en) 2016-12-20
CA2599585A1 (en) 2006-09-08
AU2006218830A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
ZA200707440B (en) Compositions and methods of making sustained release liquid formulations
EP2024476A4 (en) COMPOSITIONS WITH LOW-DP POLYMERIZED TENSIDES AND METHOD OF USE
IL190885A0 (en) Immunogenic compositions and methods of use
EP1883406A4 (en) COMPOSITIONS AND METHOD FOR CONTINUOUS RELEASE OF BETA-ALLANINE
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
IL189011A0 (en) COMPOSITIONS OF tRNA AND USES THEREOF
EP1851335A4 (en) COMPOSITIONS AND METHODS FOR USE OF STANDARDIZED MIXTURES
AP2465A (en) Terpene-containing compositions and methods of making and using them
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
HK1213814A1 (zh) 雙氯芬酸製劑和使用方法
PT2402005T (pt) Formulações de libertação sustentada de nalbufina
IL184735A0 (en) Pharmaceutical formulations and methods of use
EP1973986A4 (en) COMPLEX BIOACTIVE COMPOSITIONS AND METHODS OF USE
AP2008004392A0 (en) Compositions providing tolerance to multiple herbicides and methods of use thereof
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
EP1858535A4 (en) COMPOSITIONS WITH ACTINIDIA AND METHOD OF USE THEREOF
EP1933805A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
EP2021448A4 (en) COMPOSITIONS WITH POLYMERIZED LOW-DP TENSIDES AND METHOD OF USE THEREOF
ZA200801554B (en) Compositions providing tolerance to multiple herbicides and methods of use thereof
EP2069452A4 (en) ONIUM-HOLDING CMP COMPOSITIONS OF BIOACTIVE COMPLEXES AND METHOD FOR THEIR USE
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
IL185723A0 (en) Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
EP2021447A4 (en) COMPOSITIONS COMPRISING POLYMERIZED LOW-DP SURFACTANTS AND METHODS OF USE THEREOF
IL190583A0 (en) Pth formulations and methods of use